Last Updated: November 8, 2026

Sunshine Company Profile

« Back to Dashboard

What is the competitive landscape for SUNSHINE

SUNSHINE has twenty-nine approved drugs.

There are three tentative approvals on SUNSHINE drugs.

Summary for Sunshine

US Patents:	0
Tradenames:	25
Ingredients:	25
NDAs:	29

Drugs and US Patents for Sunshine

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sunshine	RIVAROXABAN	rivaroxaban	TABLET;ORAL	213348-001	May 14, 2025	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sunshine	BRIVARACETAM	brivaracetam	TABLET;ORAL	214748-004	Jun 9, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sunshine	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	213037-003	Oct 2, 2023	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sunshine	OLANZAPINE	olanzapine	TABLET;ORAL	206238-003	Nov 19, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sunshine	OSELTAMIVIR PHOSPHATE	oseltamivir phosphate	FOR SUSPENSION;ORAL	213594-001	Jan 5, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sunshine	AMLODIPINE BESYLATE	amlodipine besylate	TABLET;ORAL	206524-003	May 4, 2018		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Sunshine	ENTECAVIR	entecavir	TABLET;ORAL	211978-001	May 20, 2020		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.